Marta Siernicka

438 total citations
12 papers, 238 citations indexed

About

Marta Siernicka is a scholar working on Molecular Biology, Genetics and Immunology. According to data from OpenAlex, Marta Siernicka has authored 12 papers receiving a total of 238 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Genetics and 5 papers in Immunology. Recurrent topics in Marta Siernicka's work include Chronic Lymphocytic Leukemia Research (5 papers), Immune Cell Function and Interaction (5 papers) and Redox biology and oxidative stress (3 papers). Marta Siernicka is often cited by papers focused on Chronic Lymphocytic Leukemia Research (5 papers), Immune Cell Function and Interaction (5 papers) and Redox biology and oxidative stress (3 papers). Marta Siernicka collaborates with scholars based in Poland, France and Sweden. Marta Siernicka's co-authors include Radosław Zagożdżon, Agnieszka Graczyk‐Jarzynka, Małgorzata Bajor, Magdalena Winiarska, Małgorzata Firczuk, Angelika Muchowicz, Małgorzata Bobrowicz, Jakub Gołąb, Weiwen Yang and Johanna Olweus and has published in prestigious journals such as Blood, British Journal of Cancer and Immunology.

In The Last Decade

Marta Siernicka

11 papers receiving 238 citations

Peers

Marta Siernicka

ONCOL

IMMUN

PFM

GENET

Fanjun Cheng China

Roya Khorram Iran

Joanna Barankiewicz Poland

Joanna Majkut United Kingdom

Rebecca A. Luchtel United States

Tsun Ki Jerrick To United States

Peter J. Volberding United States

Annalisa Conti Italy

Guangxi Zhao China

Michelle T. Ashworth United States

Fanjun Cheng China

Marta Siernicka

120 ×1.1

ONCOL

77 ×0.7

IMMUN

111 ×1.1

28 ×0.9

PFM

17 ×0.8

GENET

Citations per year, relative to Marta Siernicka Marta Siernicka (= 1×) peers Fanjun Cheng

Countries citing papers authored by Marta Siernicka

Since Specialization

Citations

This map shows the geographic impact of Marta Siernicka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marta Siernicka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marta Siernicka more than expected).

Fields of papers citing papers by Marta Siernicka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marta Siernicka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marta Siernicka. The network helps show where Marta Siernicka may publish in the future.

Co-authorship network of co-authors of Marta Siernicka

This figure shows the co-authorship network connecting the top 25 collaborators of Marta Siernicka. A scholar is included among the top collaborators of Marta Siernicka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marta Siernicka. Marta Siernicka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Oei, Vincent Yi Sheng, Marta Siernicka, Agnieszka Graczyk‐Jarzynka, et al.. (2018). Intrinsic Functional Potential of NK-Cell Subsets Constrains Retargeting Driven by Chimeric Antigen Receptors. Cancer Immunology Research. 6(4). 467–480. 91 indexed citations

Pyrzyńska, Beata, Abdessamad Zerrouqi, Giulia Morlino, et al.. (2018). FOXO1 promotes resistance of non-Hodgkin lymphomas to anti-CD20-based therapy. OncoImmunology. 7(5). e1423183–e1423183. 18 indexed citations

Bajor, Małgorzata, Agnieszka Graczyk‐Jarzynka, Angelika Muchowicz, et al.. (2018). Targeting peroxiredoxin 1 impairs growth of breast cancer cells and potently sensitises these cells to prooxidant agents. British Journal of Cancer. 119(7). 873–884. 54 indexed citations

Siernicka, Marta, et al.. (2018). Dasatinib Effect on NK Cells and Anti-Tumor Immunity. Blood. 132(Supplement 1). 3004–3004. 3 indexed citations

Siernicka, Marta, et al.. (2018). Synergistic antitumor effects of histone deacetylase inhibitor scriptaid and bortezomib against ovarian cancer cells. Oncology Reports. 39(4). 1999–2005. 10 indexed citations

Graczyk‐Jarzynka, Agnieszka, Radosław Zagożdżon, Angelika Muchowicz, et al.. (2017). New insights into redox homeostasis as a therapeutic target in B-cell malignancies. Current Opinion in Hematology. 24(4). 393–401. 19 indexed citations

Domagała, Antoni, Małgorzata Bobrowicz, Joanna Stachura, et al.. (2016). Lysosomal Disruption Augments Obinutuzumab-Induced Direct Cell Death. Blood. 128(22). 2766–2766. 2 indexed citations

Bojarczuk, Kamil, et al.. (2015). B-cell receptor signaling in the pathogenesis of lymphoid malignancies. Blood Cells Molecules and Diseases. 55(3). 255–265. 23 indexed citations

Siernicka, Marta, Magdalena Winiarska, Małgorzata Bajor, et al.. (2015). Adenanthin, a new inhibitor of thiol‐dependent antioxidant enzymes, impairs the effector functions of human natural killer cells. Immunology. 146(1). 173–183. 16 indexed citations

10.

Bobrowicz, Małgorzata, Kamil Bojarczuk, Marta Siernicka, et al.. (2014). HDAC Inhibitors As Potential New Agents Improving the Efficacy of Monoclonal Antibodies. Blood. 124(21). 3641–3641. 1 indexed citations

11.

Siernicka, Marta, Kamil Bojarczuk, Małgorzata Bobrowicz, et al.. (2014). Influence of Btk Inhibitors on Antitumor Activity of Natural Killer Cells. Blood. 124(21). 2742–2742.

12.

Pyrzyńska, Beata, Kamil Bojarczuk, Magdalena Winiarska, et al.. (2013). Inhibitors Of Src Family and AKT Regulate The Activity Of CD20 Promoter. Blood. 122(21). 1838–1838. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact